Copolymers of poly(lactic acid) and d-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: Versatile multifunctional platforms for cancer diagnosis and therapy

Expert Opinion on Drug Delivery

Volumn 10, Issue 4, 2013, Pages 529-543

  Vijayakumar, Mahalingam R ^a   Muthu, Madaswamy S ^a   Singh, Sanjay ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Cancer; Chemotherapy; Copolymers; Diagnosis; Nanomedicines; PLA; Targetability; TPGS

Indexed keywords

CAMPTOTHECIN; COPOLYMER; CREMOPHOR; CYCLOSPORIN A; DOCETAXEL; DOXORUBICIN; EMULSIFYING AGENT; FERUCARBOTRAN; FOLATE RECEPTOR; FOLIC ACID; IRON OXIDE; LIPOSOME; MACROGOL; MULTIDRUG RESISTANCE PROTEIN; NANOPARTICLE; PACLITAXEL; PHOTOSENSITIZING AGENT; POLYLACTIC ACID; POLYSORBATE 80; PRODRUG; QUANTUM DOT; RHODAMINE B; TAMOXIFEN; TOCOFERSOLAN; TRANSFERRIN; TRASTUZUMAB;

BLOOD BRAIN BARRIER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER THERAPY; CONFOCAL LASER MICROSCOPY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; EMULSION; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; IC 50; MACROPHAGE; MICELLE; NANOENCAPSULATION; NANOFABRICATION; NANOMEDICINE; NONHUMAN; OPSONIZATION; PHOTODYNAMIC THERAPY; PROTON TRANSPORT; RETICULOENDOTHELIAL SYSTEM; REVIEW; SARCOMA 180; TUMOR MICROENVIRONMENT; ZETA POTENTIAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; LACTATES; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; POLYESTERS; POLYETHYLENE GLYCOLS; SUCCINATES;

EID: 84875180182     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.758632     Document Type: Review

References (73)

1. Bendix D. Chemical synthesis of polylactide and its copolymers for medical applications. Polym Degrad Stab 1998;59:129-35
2. Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Exp Rev Med Devices 2004;1:115-25
3. Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550-6
4. Zhang Z, Lee SH, Feng SS. Folate-decorated poly (lactide-coglycolide)- vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 2007;28:1889-99
5. Muthu MS, Feng SS. Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine (Lond.) 2010;5:1017-19
6. Ma Y, Huang L, Song C, et al. Nanoparticle formulation of poly(ecaprolactone-co-lactide)-D-alphatocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment. Polymer (Guildf) 2010;51:5952-9
7. Wang J, Wang R, Li LB. Preparation and properties of hydroxycamptothecin- loaded nanoparticles made of amphiphilic copolymer and normal polymer. J Colloid Interface Sci 2009;336:808-13
8. Liang C, Yang Y, Ling Y, et al. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma. Bioorg Med Chem 2011;19:4057-66
9. Zhang Z, Feng SS. In vitro investigation on poly(lactide)-Tween 80 copolymer nanoparticles fabricated by dialysis method for chemotherapy. Biomacromolecules 2006;7:1139-46
10. He G, Ma LL, Pan J, et al. ABA and BAB type triblock copolymers of PEG and PLA: A comparative study of drug release properties and "stealth" particle characteristics. Int J Pharm 2007;334:48-55
11. Dong Y, Feng SS. Methoxy poly (ethylene glycol)-poly(lactide) (MPEGPLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004;25:2843-9
12. Hu K, Li J, Shen Y, et al. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations. J Control Release 2009;134:55-61
13. Venkatraman SS, Jie P, Min F, et al. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. Int J Pharm 2005;298:219-32
14. Kunii R, Onishi H, Machida Y. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin. Eur J Pharm Biopharm 2007;67:9-17
15. Essa S, Michel RJ, Hildgen P. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): Effect of poly(ethylene glycol) grafting density. Int J Pharm 2011;411:178-87
16. Xiao L, Xiong X, Sun X, et al. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 2011;32:5148-57
17. Zhang Z, Xiong X, Wan X, et al. Cellular uptake and intracellular trafficking of PEG-b-PLA polymeric micelles. Biomaterials 2012;33:7233-40
18. Zhang CY, Yang YQ, Huang TX, et al. Self-assembled pH-responsive MPEG-b-(PLA-co-PAE) block copolymer micelles for anticancer drug delivery. Biomaterials 2012;33:6273-83
19. Zhao ZX, Gao SY, Wang JC, et al. Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine (R15) triblock copolymer for siRNA delivery. Biomaterials 2012;33:6793-807
20. Zhang Z, Feng SS. Nanoparticles of poly (lactide)/vitamin E TPGS copolymer for cancer chemotherapy: Synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006;27:262-70
21. Zhanga Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006;27:4025-33
22. Zhang Z, Lee SH, Gan CW, et al. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm Res 2008;25(8):1925-35
23. Zhang Z, Feng SS. Self-assembled nanoparticles of poly (lactide) -Vitamin E-TPGS copolymers for oral chemotherapy. Int J Pharm 2006;324:191-8
24. Saul JM, Annapragada A, Natarajan JV, et al. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J Control Release 2003;92:49-67
25. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41:147-62
26. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in vivo and in established cell-lines physiological and clinical implications. Cancer 1994;73:2432-43
27. Pan J, Feng SS. Targeted delivery of paclitaxel using folate-decorated poly (lactide)-vitamin E TPGS nanoparticles. Biomaterials 2008;29:2663-72
28. Gan CW, Feng SS. Transferrin-conjugated nanoparticles of Poly(lactide)-D-alpha-Tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Biomaterials 2010;31:7748-57
29. Pardridge WM. Drug targeting to the brain. Pharm Res 2007;24:1733-44
30. Cohen BE, Bangham AD. Diffusion of small non-electrolytes across liposome membrane. Nature 1972;236:173-4
31. Bogman K, Zysset Y, Degen L, et al. P-glycoprotein and surfactants: Effect on intestinal talinolol absorption. Clin Pharmacol Ther 2005;77:24-32
32. Jones AR, Shusta EV. Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 2007;24:1759-71
33. Wagner E, Curiel D, Cotton M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv Drug Deliv Rev 1994;14:113-35
34. Zhao J, Mi Y, Liu Y, Feng Y. Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend. Biomaterials 2012;33:1948-58
35. Briley-Saebo K, Bjørnerud A, Grant D, et al. Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: Implications for magnetic resonance imaging. Cell Tissue Res 2004;316:315-23
36. Prashant C, Dipak M, Yang CT, et al. Superparamagnetic iron oxide loaded poly (lactic acid) - D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials 2010;31:5588-97
37. Wu XY, Liu HJ, Liu JQ, et al. Immunofluorescent labeling of cancer marker Her 2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2003;21:41-6
38. Wang YA, Li JJ, Chen HY, et al. Stabilization of inorganic nanocrystals by organic dendrons. J Am Chem Soc 2002;124:2293-8
39. Pan J, Wang Y, Feng SS. Formulation, characterization and in vitro evaluation of quantum dots loaded in poly (lactide)-vitamin E TPGS nanoparticles for cellular and molecular imaging. Biotechnol Bioeng 2008;101:622-33
40. Jain RK. Delivery of molecular medicine to solid tumours: Lessons from in vivo imaging of gene expression and function. J Control Release 2001;74:7-25
41. Pan J, Feng SS. Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials 2009;30:1176-83
42. Tan YF, Chandrasekharan P, Maity D, et al. Multimodal tumour imaging by iron oxides and quantum dots formulated in poly (lactic acid)-D-alphatocopheryl polyethylene glycol 1000 succinate nanoparticles. Biomaterials 2011;32:2969-78
43. Sokol RJ, Butler-Simon N, Conner C, et al. Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993;104:1727-35
44. Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J Control Release 2002;80:129-44
45. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol-): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003;86:33-48
46. Feng SS, Huang GF. Effects of phospholipids as emulsifiers on controlled release of paclitaxel from nanospheres of biodegradable polymers. J Control Release 2001;71:53-69
47. Mu L, Feng SS. PLGA/TPGS nanoparticles for controlled release of paclitaxel: Effects of the emulsifier and drug loading ratio. Pharm Res 2003;20:1864-72
48. Zhang Z, Tan S, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials 2012;33:4889-906
49. Yu L, Bridgers A, Polli J, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 1999;16:1812-17
50. Gelderblom H, Verweij J, Nooter K, et al. Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 2001;37:1590-8
51. Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002;235:179-92
52. Dorr RT. Pharmacology and toxicology of cremophor EL diluent. Ann Pharmacother 1994;28:S11-14
53. Fischer JR, Harkin KR, Freeman LC. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine A in healthy dogs. Vet Ther 2002;3:465-73
54. Mu L, Seow PH, Ang SN, et al. Study on surfactant coating of polymeric nanoparticles for controlled delivery of anticancer drug. Colloid Polym Sci 2004;283:58-65
55. Feng SS, Zhao L, Zhang Z, et al. Chemotherapeutic engineering: Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168 h in vivo. Chem Eng Sci 2007;62:6641-8
56. Moan J, Berg K. The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 1991;53:549-53
57. Shieh M J, Hsu CY, Huang LY, et al. Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells. J Control Release 2011;152:418-25
58. Greenwald RB, Choe YH, McGuire J, et al. Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 2003;55:217-50
59. Feng SS. New-concept chemotherapy by nanoparticles of biodegradable polymers - where are we now? Nanomedicine (Lond) 2006;1:297-309
60. Cao N, Feng SS. Doxorubicin conjugated to D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS): Conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 2008;29:3856-65
61. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumours based on EPR effects. Adv Drug Deliv Rev 2011;63:161-9
62. Xiong S, Yu B, Wu J, et al. Preparation, therapeutic efficacy and intratumoural localization of targeted daunorubicin liposomes conjugating folate-PEG-CHEMS. Biomed Pharmacother 2011;65:2-8
63. Muthu MS, Feng SS. Theranostic liposomes for cancer diagnosis and treatment: Current development and pre-clinical success. Expert Opin Drug Deliv 2013; In press 64.
64. Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev 2006;58:1532-55
65. Abu Lila AS, Okada T, Doi Y, et al. Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumour model: Synergy or antagonism? Int J Pharm 2012;426:263-70
66. Muthu MS, Kulkarni SA, Xiong J, et al. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011;421:332-40
67. Muthu MS, Kulkarni SA, Raju A, et al. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 2012;33:3494-501
68. Wang T, Yin X, Lu Y, et al. Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin. Int J Nanomedicine 2012;7:2325-37
69. Li YP, Xiao K, Luo JT, et al. A novel size-tunable nanocarrier system for targeted anticancer drug delivery. J Control Release 2010;144:314-23
70. Gao Y, Li LB, Zhai G. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloids Surf B Biointerfaces 2008;64:194-9
71. Muthu MS, Kulkarni SA, Liu Y, et al. Development of docetaxel-loaded vitamin E TPGS micelles: Formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine (Lond) 2012;7:353-64
72. Chandrasekharan P, Maity D, Yong CX, et al. Vitamin E (D-alpha-tocopheryl-copoly (ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI. Biomaterials 2011;32:5663-72
73. Mi Y, Liu Y, Feng SS. Formulation of docetaxel by folic acid-conjugated D-a-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011;32:4058-66